Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors
Recombinant adeno-associated virus (rAAV) vectors have evolved as one of the most promising technologies for gene therapy due to their good safety profile, high transduction efficacy, and long-term gene expression in nondividing cells. rAAV-based gene therapy holds great promise for treating genetic...
Main Authors: | Ruth Rieser, Johanna Koch, Greta Faccioli, Klaus Richter, Tim Menzen, Martin Biel, Gerhard Winter, Stylianos Michalakis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/5/748 |
Similar Items
-
Comparison of analytical techniques to quantitate the capsid content of adeno-associated viral vectors
by: Amanda K. Werle, et al.
Published: (2021-12-01) -
Anion-exchange HPLC assay for separation and quantification of empty and full capsids in multiple adeno-associated virus serotypes
by: Santoshkumar L. Khatwani, et al.
Published: (2021-06-01) -
Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
by: Prabhakar Bastola, et al.
Published: (2020-08-01) -
Creation of a High-Yield AAV Vector Production Platform in Suspension Cells Using a Design-of-Experiment Approach
by: Huiren Zhao, et al.
Published: (2020-09-01) -
Adeno-Associated Virus (AAV) Versus Immune Response
by: Joseph Rabinowitz, et al.
Published: (2019-01-01)